Application of Pharmacokinetics and Pharmacodynamics to Antimicrobial Therapy of Community-Acquired Respiratory Tract Infections

By  

Respiration, Vol. 72, Iss. 6, 2005-12 ,pp. : 561-571

Karger

Access to resources Recommend Favorite

Update on the use of the macrolides for community-acquired respiratory tract infections

By Blondeau Joseph M  

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 619-650

Future Medicine

Access to resources Recommend Favorite

Therapeutic Implications of Antibacterial Resistance in Community-Acquired Respiratory Tract Infections in Children

By Cunha B.  

Infection, Vol. 32, Iss. 2, 2004-04 ,pp. : 98-108

Springer Publishing Company

Access to resources Recommend Favorite

Clinical dose findings of sitafloxacin treatment: pharmacokinetic-pharmacodynamic analysis of two clinical trial results for community-acquired respiratory tract infections

By Kohno Shigeru  

Journal of Infection and Chemotherapy, Vol. 19, Iss. 3, 2013-06 ,pp. : 486-494

Springer Publishing Company

Access to resources Recommend Favorite

Prescription rates and diagnostic patterns are stable: A comparison of high-, medium- and low-prescribing primary care physicians treating community-acquired respiratory tract infections

By Leistevuo Jorma   Huikko Solja   Rautakorpi Ulla-Maija   Leistevuo Tiina   Honkanen Pekka   Klaukka Timo   Mäkelä Marjukka   Palva Erkki   Roine Risto   Sarkkinen Hannu   Varonen Helena   Huovinen Pentti   GROUP THE MIKSTRA COLLABORATIVE STUDY  

Scandinavian Journal of Infectious Diseases, Vol. 37, Iss. 6-7, 2005-07 ,pp. : 465-470

Informa Healthcare

Access to resources Recommend Favorite